Jim Prutow

Jim Prutow

Jim Prutow is a partner at global management consulting firm PRTM (www.prtm.com). He can be reached at jprutow@prtm.com.

Recent posts

The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets
Life science tool companies have traditionally operated in the “research use only” market—selling equipment and reagents to academic labs, research centers and biopharmaceutical R&D. By selling into the research-only market, these... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!